Development of Nanocrystal Formulations With Improved Dissolution And Bioavailability for BCS Classs-II Drug- Quitapine. Journal of Pharmaceutical Negative Results. Published online August 1, 2022:5113-5120. doi:10.47750/pnr.2022.13.S08.670